Mottled mice and non-mammalian models of menkes disease

Frontiers in Molecular Neuroscience

Volumn 8, Issue DEC, 2015, Pages

  Lenartowicz, Małgorzata ^a   Krzeptowski, Wojciech ^a   Lipiński, Paweł ^b   Grzmil, Paweł ^a   Starzyński, Rafał ^b   Pierzchała, Olga ^a   Møller, Lisbeth Birk ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF GENETICS AND ANIMAL BREEDING   (Poland)

^c Rigshospitalet   (Denmark)

Author keywords

ATP7A; Copper metabolism; Menkes disease; Mottled mice

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA INTERMEDIN; ASPARTIC ACID; CERULOPLASMIN; CHOLECYSTOKININ; COPPER; GLUTAMIC ACID; MENKES PROTEIN; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATP7A GENE; AUTOPHOSPHORYLATION; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CONNECTIVE TISSUE DISEASE; COPPER DEFICIENCY; COPPER METABOLISM; DEPHOSPHORYLATION; DROSOPHILA MELANOGASTER; EPILEPSY; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; HOMEOSTASIS; HOUSEKEEPING GENE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MENKEN DISEASE; METABOLIC DISORDER; METABOLIC SYNDROME X; MOTOR NEUROPATHY; MOUSE; NERVE DEGENERATION; NONHUMAN; REVIEW; SEIZURE; SYNAPTOGENESIS; THERMOREGULATION; TRANS GOLGI NETWORK; ZEBRA FISH;

EID: 84957805357     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2015.00072     Document Type: Review

References (164)

1. Arredondo, M., Munoz, P., Mura, C. V., and Nunez, M. T. (2003). DMT1, a physiologically relevant apical Cu+ transporter of intestinal cells. Am. J. Physiol. CellPhysiol. 284,C1525-C1530. doi: 10.1152/ajpcell.00480.2002
2. Bahadorani, S., Bahadorani, P., Marcon, E., Walker, D. W., and Hilliker, A. J. (2010). A Drosophila model of Menkes disease reveals a role for DmATP7 in copper absorption and neurodevelopment. Dis. Model. Mech. 3, 84-91. doi: 10.1242/dmm.002642
3. Bahi-Buisson, N., Kaminska, A., Nabbout, R., Barnerias, C., Desguerre, I., De Lonlay, P., et al. (2006). Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia 47, 380-386. doi: 10.1111/j.1528-1167.2006.00432.x
4. Barry, A. N., Shinde, U., and Lutsenko, S. (2010). Structural organization ofhuman Cu-transporting ATPases: learning from building blocks. J. Biol. Inorg. Chem. 15, 47-59. doi: 10.1007/s00775-009-0595-4
5. Beaumont, C. (2010). Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages. Haematologica 95, 1233-1236. doi: 10.3324/hemeatol.2010.025585
6. Bhadhprasit, W., Kodama, H., Fujisawa, C., Hiroki, T., and Ogawa, E. (2012). Effect of copper and disulfiram combination therapy on the macular mouse, a model of Menkes disease. J. Trace Elem. Med. Biol. 26, 105-108. doi: 10.1016/j.jtemb.2012.05.002
7. Bill, B. R., Petzold, A. M., Clark, K. J., Schimmenti, L. A., and Ekker, S. C. (2009). A primer for morpholino use in zebrafish. Zebrafish 6, 69-77. doi: 10.1089/zeb.2008.0555
8. Bousquet-Moore, D., Mains, R. E., and Eipper, B. A. (2010). Peptidylgycine a-amidating monooxygenase and copper: a gene-nutrient interaction critical to nervous system function. J. Neurosci. Res. 88, 2535-2545. doi: 10.1002/jnr.22404
9. Burke, R., Commons, E., and Camakaris, J. (2008). Expression and localization of the essential copper transporter DmATP7 in Drosophila neuronal and intestinaltissues. Int.J. Biochem. CeUBiol 40,1850-1860. doi: 10.1016/j.biocel.2008.01.021
10. Camakaris, J., Mann, J. R., and Danks, D. M. (1979). Copper metabolism in mottled mouse mutants: copper concentrations in tissues during development. Biochem.J. 180, 597-604. doi: 10.1042/bj1800597
11. Cecchi, C., and Avner, P. (1996). Genomic organization of the mottled gene, the mouse homolog of the human Menkes disease gene. Genomics 37, 96-104. doi: 10.1006/geno.1996.0525
12. Cecchi, C., Bissotto, M., Tosi, M., and Avner, P. (1997). The mottled mouse as a model for human Menkes disease: identification of mutations in the Atp7a gene. Hum. Mol. Genet. 6, 425-433. doi: 10.1093/hmg/6.3.425
13. Chen, D. S., and Chan, K. M. (2011). PCR-cloning of tilapia ATP7A cDNA and its mRNA levels in tissues of tilapia following copper administrations. Aquat. Toxicol. 105, 717-727. doi: 10.1016/j.aquatox.2011.09.011
14. Chen, H., Huang, G., Su, T., Gao, H., Attieh, Z. K., McKie, A. T., et al. (2006). Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J. Nutr. 136, 1236-1241.
15. Chen, H. R., Yang, H. C., Hsieh, D. J. Y., Liu, Z., and Tsai, K. J. (2011). Zebrafish sod1 and sp1 expression are modulated by the copper ATPase gene atp7a in response to intracellular copper status. Chem. Biol. Interact. 189, 192-197. doi: 10.1016/j.cbi.2010.12.003
16. Choi, B. S., and Zheng, W. (2009). Copper transport to the brain by the blood-brain barrier and blood CSF barrier. Brain Res. 1248, 14-21. doi: 10.1016/j.brainres.2008.10.056
17. Christodoulou, J., Danks, D. M., Sarkar, B., Baerlocher, K. E., Casey, R., Horn, N., et al. (1998). Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am. J. Med. Genet. 76, 154-164. doi: 10.1002/(sici)1096-8628(19980305)76:2<154::aid-ajmg9>3.0.co;2-t
18. Collins, J. F., and Klevay, L. M. (2011). Copper. Adv. Nutr. 2, 520-522. doi: 10.3945/an.111.001222
19. Collins, J. F., Prohaska, J. R., and Knutson, M. (2010). Metabolic crossroads of iron and copper. Nutr. Rev. 68, 133-147. doi: 10.1111/j.1753-4887.2010.00271.x
20. Cunliffe, P., Reed, V., and Boyd, Y. (2001). Intragenic deletions at Atp7a in mouse models for Menkes disease. Genomics 74, 155-162. doi: 10.1006/geno.2001.6529
21. Das, S., Levinson, B., Vulpe, C., Whitney, S., Gitschier, J., and Packman, S. (1995). Similar splicingmutations oftheMenkes/mottled copper-transportingATPase gene in occipital horn syndrome and the blotchy mouse. Am. J. Hum. Genet. 56, 570-576.
22. De Domenico, I., Ward, D. M., di Patti, M. C., Jeong, S. Y., David, S., Musci, G., et al. (2007). Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 26, 2823-2831. doi: 10.1038/sj.emboj.7601735
23. Donsante, A., Johnson, P., Jansen, L. A., and Kaler, S. G. (2010). Somatic mosaicism inMenkes disease suggests choroid plexus-mediated copper transport to the developingbrain. Am. J. Med. Genet. A 152, 2529-2534. doi: 10.1002/ajmg.a.33632
24. Donsante, A., Sullivan, P., Goldstein, D. S., Brinster, L. R., and Kaler, S. G. (2013). L-threo-dihydroxyphenylserine corrects neurochemical abnormalities in a Menkes disease mouse model. Ann. Neurol. 73, 259-265. doi: 10.1002/ana.23787
25. Donsante, A., Yi, L., Zerfas, P. M., Brinster, L. R., Sullivan, P., Goldstein, D. S., et al. (2011). ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model. Mol. Ther. 19, 2114-2123. doi: 10.1038/mt.2011.143
26. Eipper, B. A., Milgram, S. L., Husten, E. J., Yun, H. Y., and Mains, R. E. (1993). Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing and routing domains. Protein Sci. 2, 489-497. doi: 10.1002/pro.5560020401
27. Eipper, B. A., Stoffers, D. A., and Mains, R. E. (1992). The biosynthesis of neuropeptides: peptide alpha-amidation. Annu. Rev. Neurosci. 15, 57-85. doi: 10.1146/annurev.neuro.15.1.57
28. El Meskini, R., Cline, L. B., Eipper, B. A., and Ronnett, G. V. (2005). The developmentally regulated expression of Menkes protein ATP7A suggests a role in axon extension and synaptogenesis. Dev. Neurosci. 27, 333-348. doi: 10.1159/000086713
29. Fraser, A. S., Nay, T., and Turner, H. N. (1953). Growth of the mouse coat. II. Effect of sex and pregnancy. Aust. J. Biol. Sci. 6, 645-656.
30. Fujibayashi, Y., Wada, K., Taniuchi, H., Yonekura, Y., Konishi, J., andYokoyama, A. (1993). Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging. Biol. Pharm. Bull. 16, 146-149. doi: 10.1248/bpb.16.146
31. Gaier, E. D., Eipper, B. A., and Mains, R. E. (2013a). Copper signaling in the mammalian nervous system: synaptic effects. J. Neurosci. Res. 91, 2-19. doi: 10.1002/jnr.23143
32. Gaier, E. D., Miller, M. B., Ralle, M., Aryal, D., Wetsel, W. C., Mains, R. E., et al. (2013b). Peptidylglycine a-amidating monooxygenase heterozygosity alters brain copper handling with region specificity. J. Neurochem. 127, 605-619. doi: 10.1111/jnc.12438
33. Godwin, S. C., Shawker, T., Chang, B., and Kaler, S. G. (2006). Brachial artery aneurysms in Menkes disease. J. Pediatr. 149, 412-415. doi: 10.1016/j.jpeds.2006.05.041
34. Gourdon, P., Liu, X. Y., Skjørringe, T., Morth, J. P., Møller, L. B., Pedersen, B. P., et al. (2011). Crystal structure of a copper-transportingPIB-type ATPase. Nature 29, 59-64. doi: 10.1038/nature10191
35. Green, M. C. (1981). ‘‘Catalog of mutant genes and polymorphic loci,’’ in Genetic Variants and Strains of the Laboratory Mouse, eds M. F. Lyon and A. G. Searle (Oxford: Oxford UniversityPress), 162-166.
36. Greenspan, R. J., and Dierick, H. (2004). ‘Am not I a fly like thee?’ From genes in fruit flies to behavior in humans. Hum. Mol. Genet. 13, R267-R273. doi: 10.1093/hmg/ddh248
37. Grimes, A., Hearn, C. J., Lockhart, P., Newgreen, D. F., and Mercer, J. F. (1997). Molecular basis of the brindled mouse mutant (Mo(br)): a murine model of Menkes disease. Hum. Mol. Genet. 6, 1037-1042. doi: 10.1093/hmg/6.7.1037
38. Gruneberg, H. (1969). Threshold phenomena versus cell heredity in the manifestation of sex-linked genes in mammals. J. Embryol. Exp. Morphol. 22, 145-179.
39. Gulec, S., and Collins, J. F. (2013). Investigation of iron metabolism in mice expressing a mutant Menke’s copper transporting ATPase (Atp7a) protein with diminished activity (Brindled; MoBr/y). PLoS One 8:e66010.doi: 10.1371/journal.pone.0066010
40. Gulec, S., and Collins, J. F. (2014). Silencing the Menkes copper-transporting ATPase (Atp7a) gene in rat intestinal epithelial (IEC-6) cells increases iron flux via transcriptional induction of ferroportin 1 (Fpn1). J. Nutr. 144, 12-19. doi: 10.3945/jn.113.183160
41. Haddad, M. R., Patel, K. D., Sullivan, P. H., Goldstein, D. S., Murphy, K. M., Centeno, J. A., et al. (2014). Molecular and biochemical characterization of mottled-dappled, an embryonic lethal Menkes disease mouse model. Mol. Genet. Metab. 113, 294-300. doi: 10.1016/j.ymgme.2014.10.001
42. Hardman, B., Manuelpillai, U., Wallace, E. M., van der Wasenburg, S., Carter, M., Mercer, J. F., et al. (2004). Expression and localization of Menkes and Wilson copper transportingATPases in human placenta. Placenta 25, 512-517. doi: 10.1016/j.placenta.2003.11.013
43. Hardman, B., Michalczyk, A., Greenough, M., Camakaris, J., Mercer, J., and Ackland, L. (2007). Distinct functional roles for the Menkes and Wilson copper translocating P-type ATPases in human placental cells. Cell. Physiol. Biochem. 20, 1073-1084. doi: 10.1159/000110718
44. Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T., and Gitlin, J. D. (1995). Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 28,2539-2543. doi: 10.1073/pnas.92.7.2539
45. Hodgkinson, V. L., Dale, J. M., Garcia, M. L., Weisman, G. A., Lee, J., Gitlin, J. D., et al. (2015). X-linked spinal muscular atrophyin mice caused by autonomous loss ofATP7Ain the motorneuron. J.Pathol. 236, 241-250. doi: 10.1002/path.4511
46. Hua, H., Gunther, V., Georgiev, O., and Schaffner, W. (2011). Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila. Biometals 24,445-453. doi: 10.1007/s10534-011-9438-1
47. Hunt, D. M. (1974). Primary defect in copper transport underlies mottled mutants in the mouse. Nature 249, 852-854. doi: 10.1038/249852a0
48. Iwase, T., Nishimura, M., Sigimura, H., Igarashi, H., Ozawa, F., Shinmura, K., et al. (1996). Localization of Menkes gene expression in the mouse brain; its association with neurological manifestation in Menkes model mice. Acta Neuropathol. 91,482-488. doi: 10.1007/s004010050455
49. Kaler, S. G. (1998). Metabolic and molecular bases ofMenkes disease and occipital horn syndrome. Pediatr. Dev. Pathol. 1, 85-98. doi: 10.1007/s100249900011
50. Kaler, S. G. (2011). ATP7A-related copper transport diseases-emerging concepts and future trends. Nat. Rev. Neurol. 7, 15-29. doi: 10.1038/nrneurol.2010.180
51. Kaler, S. G., Buist, N. R. M., Holmes, C. S., Goldstein, D. S., Miller, R. C., and Gahl, W. A. (1995). Early copper therapy in classic Menkes disease patients with a novel splicingmutation. Ann. Neurol. 38, 921-928. doi: 10.1002/ana.410380613
52. Kaler, S. G., Holmes, C. S., Goldstein, D. S., Tang, J., Godwin, S. C., Donsante, A., et al. (2008). Neonatal diagnosis and treatment of Menkes disease. N. Engl. J. Med. 358, 605-614. doi: 10.1056/NEJMoa070613
53. Kaler, S. G., Liew, C. J., Donsante, A., Hicks, J. D., Sato, S., and Greenfield, J. C. (2010). Molecular correlates of epilepsyin early diagnosed and treated Menkes disease. J. Inherit. Metab. Dis. 33, 583-589. doi: 10.1007/s10545-010-9118-2
54. Kasama, T., and Tanaka, H. (1989). Effects of oral copper administration to pregnant heterozygous brindled mice on faetal viability and copper levels. J. Nutr. Sci. Vitaminol. (Tokyo) 35, 627-638. doi: 10.3177/jnsv.35.627
55. Kemppainen, R., Hamalainen, E. R., Kuivaniemi, H., Tromp, G., Pihlajaniemi, T., and Kivirikko, K. I. (1996). Expression of mRNAs for lysyl oxidase and type III procollagen in cultured fibroblasts from patients with the Menkes and occipital horn syndromes as determined by quantitative polymerase chain reaction. Arch. Biochem. Biophys. 328, 101-106. doi: 10.1006/abbi.1996.0148
56. Kennerson, M. L., Nicholson, G. A., Kaler, S. G., Kowalski, B., Mercer, J. F., Tang, J., et al. (2010). Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am. J. Hum. Genet. 86, 343-352. doi: 10.1016/j.ajhg.2010.01.027
57. Kim, B. E., and Petris, M. J. (2007). Phenotypic diversity of Menkes disease in mottled mice is associated with defects in localization and trafficking of the ATP7A protein. J. Med. Genet. 44, 641-646. doi: 10.1136/jmg.2007.049627
58. Kirby, J. B., Danks, D. M., Legge, G. J. F., and Mercer, J. F. B. (1998). Analysis of the distribution of Cu, Fe and Zn and other elements in brindled mouse kidney using a scanning proton microprobe. J. Inorg. Biochem. 71, 189-197. doi: 10.1016/s0162-0134(98)10053-3
59. Kirby, K., Jensen, L. T., Binnington, J., Hilliker, A. J., Ulloa, J., Culotta, V. C., et al. (2008). Instability of superoxide dismutase 1 of Drosophila in mutants deficient for its cognate copper chaperone. J. Biol. Chem. 283, 35393-35401. doi: 10.1074/jbc.m807131200
60. Kodama, H. (1993). Recent developments in Menkes disease. J. Inherit. Metab. Dis. 16, 791-799. doi: 10.1007/bf00711911
61. Kodama, H., Abe, T., Takama, M., Takahashi, I., Kodama, M., and Nishimura, M. (1993). Histochemical localization of copper in the intestine and kidney of macular mice: light and electron microscopic study. J. Histochem. Cytochem. 41, 1529-1535. doi: 10.1177/41.10.8245411
62. Kodama, H., Fujisawa, C., and Bhadhprasit, W. (2011). Pathology, clinical features and treatments of congenital copper metabolic disorders-focus on neurologic aspects. Brain Dev. 33, 243-251. doi: 10.1016/j.braindev.2010.10.021
63. Kodama, H., Fujisawa, C., and Bhadhprasit, W. (2012). Inherited copper transport disorders: biochemical mechanisms, diagnosis and treatment. Curr. Drug. Metab. 13, 237-250. doi: 10.2174/138920012799320455
64. Kodama, H., Sato, E., Gu, Y. H., Shiga, K., Fujisawa, C., and Kozuma, T. (2005). Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease. J. Inherit. Metab. Dis. 28, 971-978. doi: 10.1007/s10545-005-0150-6
65. Kowal, M., Lenartowicz, M., Pecio, A., Golas, A., Blaszkiewicz, T., and Styrna, J. (2010). Copper metabolism disorders affect testes structure and gamete quality in male mice. Syst. Biol. Reprod. Med. 56, 431-444. doi: 10.3109/19396361003734624
66. Kuivaniemi, H., Peltonen, L., and Kivirikko, K. I. (1985). Type IX Ehlers-Danlos syndrome and Menkes syndrome: the decrease in lysyl oxidase activity is associated with a corresponding deficiency in the enzyme protein. Am. J. Hum. Genet. 37, 798-808.
67. Kuo, Y. M., Gitshier, J., and Packman, S. (1997). Developmental expression of the mouse mottled and toxic milk genes suggest distinct functions for the Menkes and Wilson disease copper transporters. Hum. Mol. Genet. 6, 1043-1049. doi: 10.1093/hmg/6.7.1043
68. La Fontaine, S., Firth, S. D., Lockhart, P. J., Brooks, H., Camacaris, J., and Mercer, J. F. (1999). Intracellularlocalization and loss ofcopper responsivenessofMnk, the murine homology of the Menkes protein, in cells from blotchy (Moblo) and brindled (Mobr) mouse mutants. Hum. Mol. Genet. 8, 1069-1075. doi: 10.1093/hmg/8.6.1069
69. La Fontaine, S., and Mercer, J. F. (2007). Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch. Biochem. Biophys. 463, 149-167. doi: 10.1016/j.abb.2007.04.021
70. Lenartowicz, M., Grzmil, P., Rusin, M., and Styrna, J. (2004). Alternative splicing in the Atp7a gene in the Cu deficient mosaic mutation in mice. Folia Biol. (Krakow) 52, 219-223. doi: 10.3409/1734916044527610
71. Lenartowicz, M., Grzmil, P., Shoukier, M., Starzyiiski, R., Marciniak, M., and Lipinski, P. (2012a). Mutation in the CPC motif-containing 6th transmembrane domain affects intracellular localization, trafficking and copper transport efficiency of ATP7A protein in mosaic mutant mice-an animal model of Menkes disease. Metallomics 4, 197-204. doi: 10.1039/c1mt00134e
72. Lenartowicz, M., Krzeptowski, W., Koteja, P., Chrzascik, K., and Moller, L. B. (2012b). Prenatal treatment of mosaic mice (Atp7a mo-ms) mouse model for Menkes disease, with copper combined by dimethyldithiocarbamate (DMDT). PLoS One 7:e40400. doi: 10.1371/journal.pone.0040400
73. Lenartowicz, M., Kowal, M., Buda-Lewandowska, D., and Styrna, J. (2002). Pathological structure of the kidney from the adult mice with mosaic mutation. J. Inherit. Metab. Dis. 25, 647-659. doi: 10.1023/A:1022877130344
74. Lenartowicz, M., and Sasula, K. (2000). Altered copper metabolism in the mosaic mutant mice. Nutr. Res. 10, 1519-1529. doi: 10.1016/s0271-5317(00)00230-x
75. Lenartowicz, M., Sasula, K., and Zawadowska, B. (2001). Alterations in kidney morphology in mice with mosaic mutation. Folia Histochem. Cytobiol. 39, 275-281.
76. Lenartowicz, M., Starzynski, R. R., Krzeptowski, W., Grzmil, P., Bednarz, A., Ogorek, M., et al. (2014). Haemolysis and perturbations in the systemic iron metabolism of suckling, copper-deficient mosaic mutant mice-an animal model of Menkes disease. PLoS One 9:e107641. doi: 10.1371/journal.pone.0107641
77. Lenartowicz, M., Starzynski, R., Wieczerzak, K., Krzeptowski, W., Lipinski, P., and Styrna, J. (2011). Alterations in the expression of the Atp7a gene in the early postnatal development in the mosaic mutant mice (Atp7amo-ms)-an animal model of Menkes disease. Gene. Expr. Patterns 11, 41-47. doi: 10.1016/j.gep.2010.09.001
78. Lenartowicz, M., Windak, R., Tylko, G., Kowal, M., and Styrna, J. (2010). Effects of copper supplementation on the structure and content of elements in kidneys of mosaicmutantmice. Biol. TraceElem. Res. 136,204-220.doi: 10.1007/s12011-009-8533-4
79. Leung, K. P., Chen, D., and Chan, K. M. (2014). Understanding copper sensitivity in zebrafish (Danio rerio) through the intracellular localization of copper transporters in a hepatocyte cell-line ZFL and the tissue expression profiles of copper transporters. Metallomics 6, 1057-1067. doi: 10.1039/c3mt00366c
80. Levinson, B., Vulpe, C., Elder, B., Martin, C., Verley, F., Packman, S., et al. (1994). The mottled gene is the mouse homolog of the Menkes disease gene. Nat. Genet. 6, 369-373. doi: 10.1038/ng0494-369
81. Linz, L., and Lutsenko, S. (2007). Copper-transporting ATP-ases ATP7A and ATP7B cousins, not twins. J. Bioenerg. Biomembr. 39, 403-407. doi: 10.1007/s10863-007-9101-2
82. Lipnski, P., Stys, A., and Starzynski, R. R. (2013). Molecular insights into the regulation of iron metabolism during the prenatal and early postnatal periods. Cell. Mol. Life Sci. 70, 23-38. doi: 10.1007/s00018-012-1018-1
83. Llanos, R. M., Ke, B. X., Wright, M., Deal, Y., Monty, F., Kremer, D. R., et al. (2006). Correction of a mouse model of human Menkes disease by human Menkes gene. Biochim. Biophys. Acta 1762, 485-493. doi: 10.1016/j.bbadis.2005.12.011
84. Lopez, V., Suzuki, Y. A., and Lonnerdal, B. (2006). Ontogenic changes in lactoferrin receptor and DMT1 in mouse small intestine: implications for iron absorption during early life. Biochem. Cell Biol. 84, 337-344. doi: 10.1139/o06-059
85. Lutsenko, S., Barnes, N. L., Bartee, M. Y., and Dymitriev, O. Y. (2007). Function and regulation of human copper-transporting ATPases. Physiol. Rev. 87, 1011-1046. doi: 10.1152/physrev.00004.2006
86. Lutsenko, S., Bhattacharjee, A., and Hubbard, A. L. (2010). Copper handling machinery of the brain. Metallomics 2, 596-608. doi: 10.1039/c0mt00006j
87. Lyon, M. F. (1962). Sex chromatin and gene action in the mammalian X-chromosome. Am. J. Hum. Genet. 14, 135-148.
88. Madsen, E. C., and Gitlin, J. D. (2008). Zebrafish mutants calamity and catastrophe define critical pathways of gene-nutrient interactions in developmental copper metabolism. PLoS Genet. 4:e1000261. doi: 10.1371/journal.pgen.1000261
89. Madsen, E. C., Morcos, P. A., Mendelsohn, B. A., and Gitlin, J. D. (2008). In vivo correction of a Menkes disease model using antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 105,3909-3914. doi: 10.1073/pnas.0710865105
90. Marchler-Bauer, A., Derbyshire, M. K., Gonzales, N. R., Lu, S., Chitsaz, F., Geer, L. Y., et al. (2015). CDD: NCBI’s conserved domain database. Nucleic Acids Res. 43, D222-D226. doi: 10.1093/nar/gku1221
91. McArdle, H. J., and Erlich, R. (1991). Copper uptake and transfer to the mouse fetus during pregnancy. J. Nutr. 121, 208-214.
92. Mendelsohn, B. A., Yin, C., Johnson, S. L., Wilm, T. P., Solnica-Krezel, L., and Gitlin, J. D. (2006). Atp7a determines a hierarchy of copper metabolism essential for notochord development. Cell Metab. 4, 155-162. doi: 10.1016/j.cmet.2006.05.001
93. Menkes, J. H., Alter, M., Steigleder, G. K., Weakley, D. R., and Sung, J. H. (1962). A sex-linked recessive disorder with retardation of growth, peculiar hair and focal cerebral and cerebellar degeneration. Pediatrics 29, 764-779.
94. Mercer, J. F., Ambrosini, L., Horton, S., Gazeas, S., and Grimes, A. (1999). Animal models of Menkes disease. Adv. Exp. Med. Biol. 448, 97-108. doi: 10.1007/978-1-4615-4859-1_8
95. Mercer, J. F. B., Grimes, A., Ambrosini, L., Lockhart, P., Paynter, J. A., Dierick, H., et al. (1994). Mutations in the murine homologue of the Menkes gene in dappled and blotchy mice. Nat. Genet. 6, 374-378. doi: 10.1038/ng0494-374
96. Mercer, J. F., Grimes, A., and Rauch, H. (1992). Hepatic metallothionein gene expression in toxic milk mice. J. Nutr. 122, 1254-1259.
97. Møller, L. B., Bukrinsky, J. T., Mølgaard, A., Paulsen, M., Lund, C., Tumer, Z., et al. (2005). Identification and analysis of 21 novel disease-causing amino acid substitutions in the conserved part of ATP7A. Hum. Mutat. 26, 84-93. doi: 10.1002/humu.20190
98. Møller, L. B., Mogensen, M., and Horn, N. (2009). Molecular diagnosis of Menkes disease: genotype-phenotype correlation. Biochimie 91, 1273-1277. doi: 10.1016/j.biochi.2009.05.011
99. Møller, L. B., Tumer, Z., Lund, C., Petersen, C., Cole, T., Hanusch, R., et al. (2000). Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. Am. J. Hum. Genet. 66, 1211-1220. doi: 10.1086/302857
100. Mori, M., and Nishimura, A. (1997). A serine-to-proline mutation in the copper-transporting P-type ATPase gene of the macular mouse. Mamm. Genome 8, 407-410.doi: 10.1007/s003359900457
101. Mototani, Y., Miyoshi, I., Okamura, T., Moriya, T., Meng, Y., Yuan Pei, X., et al. (2006). Phenotypic and genetic characterization of the Atp7a(Mo-Tohm) mottled mouse: anewmurine model ofMenkes disease. Genomics 87,191-199. doi: 10.1016/j.ygeno.2005.09.011
102. Munakata, M., Kodama, H., Fujisawa, C., Hiroki, T., Kimura, K., Watanabe, M., et al. (2012). Copper-trafficking efficacy of copper-pyruvaldehyde bis(N4-methylthiosemicarbazone) on the macular mouse, an animal model ofMenkes disease. Pediatr. Res. 72, 270-276. doi: 10.1038/pr.2012.85
103. Murata, Y., Kodama, H., Abe, T., Ishida, N., Nishimura, M., Lewinson, B., et al. (1997). Mutation analysis and expression of the mottled gene in the macular mouse model of Menkes disease. Pediatr. Res. 42, 436-442. doi: 10.1203/00006450-199710000-00003
104. Nadal, D., and Baerlocher, K. (1988). Menkes’ disease: long-term treatment with copper and D-penicillamine. Eur. J. Pediatr. 147, 621-625. doi: 10.1007/bf00442477
105. Nakagawa, S., Adachi, R., Mijake, M., Hama, T., Tanaka, K., and Mayumi, T. (1993). Production of normal macular mouse chimeras: the presence of critical tissue in the macular mutant mouse, a model of Menkes’ kinky hair disease. Zool. Scie. 10, 653-660.
106. Nelson, K. T., and Prohaska, J. R. (2009). Copper deficiency in rodents alters dopamine beta-mono-oxygenase activity, mRNA and protein level. Br. J. Nutr. 102, 18-28. doi: 10.1017/s0007114508162961
107. Niciu, M. J., Ma, X. M., El Meskini, R., Pachter, J. S., Mains, R. E., and Eipper, B. A. (2007). Altered ATP7A expression and other compensatory responses in a murine model ofMenkes disease. Neurobiol Dis. 27, 278-291. doi: 10.1016/j.nbd.2007.05.004
108. Niciu, M. J., Ma, X. M., El Meskini, R., Ronnett, G. V., Mains, R. E., and Eipper, B. A. (2006). Developmental changes in the expression of the Atp7a during a critical period in postnatal neurodevelopment. Neuroscience 139, 947-964. doi: 10.1016/j.neuroscience.2006.01.044
109. Nie, Y., Schoepp, D. D., Klaunig, J. E., Yard, M., Lahiri, D. K., and Kubek, M. J. (2005). Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro. Brain Res. 1054, 45-54. doi: 10.1016/j.brainres.2005.06.077
110. Norgate, M., Lee, E., Southon, A., Farlow, A., Batterham, P., Camakaris, J., et al. (2006). Essential roles in development and pigmentation for the Drosophila copper transporter DmATP7. Mol. Biol. Cell 17, 475-484. doi: 10.1091/mbc.e05-06-0492
111. Norgate, M., Southon, A., Zou, S., Zhan, M., Sun, Y., Batterham, P., et al. (2007). Copper homeostasis gene discovery in Drosophila melanogaster. Biometals 20, 683-697. doi: 10.1007/s10534-006-9075-2
112. Otoikhian, A., Barry, A. N., Mayfield, M., Nilges, M., Huang, Y., Lutsenko, S., et al. (2012). Lumenal loop M672-P707 of the Menkes protein (ATP7A) transfers copper to peptidylglycine monooxygenase. J. Am. Chem. Soc. 134, 10458-10468. doi: 10.1021/ja301221s
113. Patel, B. N., and David, S. (1997). A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272, 20185-20190. doi: 10.1074/jbc.272.32.20185
114. Petris, M. J., Strausak, D., and Mercer, J. F. (2000). The Menkes copper transporter is required for the activation of tyrosinase. Hum. Mol. Genet. 9, 2845-2851. doi: 10.1093/hmg/9.19.2845
115. Phillips, M., Camakaris, J., and Danks, D. M. (1986). Comparisons of copper deficiency states in the murine mutants blotchy and brindled. Changes in copper-dependent enzyme activity in 13-day-old mice. Biochem. J. 238, 177-183. doi: 10.1042/bj2380177
116. Phillips, M., Camakaris, J., and Danks, D. M. (1991). A comparison of phenotype and copper distribution in blotchy and brindled mutant mice and in nutritionallycopperdeficientcontrols. Biol. TraceElem. Res. 29,11-29. doi: 10.1007/bf03032670
117. Phillips, J. B., and Westerfield, M. (2014). Zebrafish models in translational research: tipping the scales toward advancements in human health. Dis. Model. Mech. 7, 739-743. doi: 10.1242/dmm.015545
118. Poulsen, L., Horn, N., Heilstrup, H., Lund, C., Tumer, Z., and Møller, L. B. (2002). X-linked recessive Menkes disease: identification of partial gene deletions in affected males. Clin. Genet. 62, 449-457. doi: 10.1034/j.1399-0004.2002.620605.x
119. Prasad, A. N., Levin, S., Rupar, C. A., and Prasad, C. (2011). Menkes disease and infantile epilepsy. Brain Dev. 33, 866-876. doi: 10.1016/j.braindev.2011.08.002
120. Prohaska, J. R. (1983). Changes in tissue growth, concentrations of copper, iron, cytochrome oxidase and superoxide dismutase subsequent to dietary or genetic copper deficiencyin mice. J. Nutr. 113, 2048-2058.
121. Prohaska, J. R. (1988). Effect of dietary copper deficiency on heterozygous female brindled mice. Nutr. Res. 8, 1079-1084. doi: 10.1016/s0271-317(88)80063-0
122. Prohaska, J. R. (2011). Impact of copper limitation on expression and function of multicopper oxidases (ferroxidases). Adv. Nutr. 2, 89-95. doi: 10.3945/an.110.000208
123. Prohaska, J. R., and Broderius, K. (2006). Plasma peptidylglycine alpha-amidating monooxygenase (PAM) and ceruloplasmin are affected by age and copper status in rats and mice. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 143, 360-366. doi: 10.1016/j.cbpb.2005.12.010
124. Proud, V. K., Mussell, H. G., Kaler, S. G., Young, D. W., and Percy, A. K. (1996). Distinctive Menkes disease variant with occipital horns: delineation of natural history and clinical phenotype. Am. J. Med. Genet. 65, 44-51. doi: 10.1002/(sici)1096-8628(19961002)65:1<44::aid-ajmg7>3.0.co;2-y
125. Qi, M., and Byers, P. H. (1998). Constitutive skipping of alternatively spliced exon 10 in the ATP7A gene abolishes Golgi localization of the Menkes protein and produces the occipital horn syndrome. Hum. Mol. Genet. 7, 465-469. doi: 10.1093/hmg/7.3.465
126. Reed, V., and Boyd, Y. (1997). Mutation analysis provides additional proof that mottled is the mouse homolog ofMenkes disease. Hum. Mol. Genet. 6,417-423. doi: 10.1093/hmg/6.3.417
127. Richichi, C., Lin, E. J., Stefanin, D., Colella, D., Ravizza, T., Grignaschi, G., et al. (2004). Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci. 24, 3051-3059. doi: 10.1523/jneurosci.4056-03.2004
128. Rowe, D. W., McGoodwin, E. B., Martin, G. R., Sussman, M. D., Grahn, D., Faris, B., et al. (1974). A sex-linked defect in the cross-linking of collagen and elastin Animal Models of Menkes Disease Lenartowicz et al. associated with the mottled locus in mice. J. Exp. Med. 139, 180-192. doi: 10.1084/jem.139.1.180
129. Royce, P. M., Camakaris, J., Mann, J. R., and Danks, D. M. (1982). Copper metabolism in mottled mouse mutants. The effect of copper therapy on lysyl oxidase activity in brindled (Mobr) mice. Biochem. J. 202, 369-371. doi: 10.1042/bj2020369
130. Royce, P. M., and Steinmann, B. (1990). Markedlyreduced activity oflysyl oxidase in skin and aorta from a patient with Menkes’ disease showing unusually severe connective tissue manifestations. Pediatr. Res. 28, 137-141. doi: 10.1203/00006450-199008000-00012
131. Rucker, R. B., Kosonen, T., Clegg, M. S., Mitchell, A. E., Rucker, B. R., Uriu-Hare, J. Y., et al. (1998). Copper, lysyl oxidase and extracellular matrix protein crosslinking. Am. J. Clin. Nutr. 67, S996-S1002.
132. Sellami, A., Wegener, C., and Veenstra, J. A. (2012). Functional significance of the copper transporter ATP7 in peptidergic neurons and endocrine cells in Drosophila melanogaster. FEBS Lett. 586, 3633-3638. doi: 10.1016/j.febslet.2012.08.009
133. Shibata, N., Hirano, A., Kobayashi, M., Umahara, T., Kawanami, T., and Asayama, K. (1995). Cerebellar superoxide dismutase expression in Menkes’ kinky hair disease: an immunohistochemical investigation. Acta Neuropathol. 90, 198-202. doi: 10.1007/bf00294321
134. Shiraishi, N., Aono, K., and Tagauchi, T. (1988). Copper metabolism in the macular mutant mouse: an animal model of Menkes Kinky-Hair disease. Biol. Neonate 54, 173-180. doi: 10.1159/000242849
135. Silberberg, R. (1977). Epiphyseal growth and osteoarthrosis in blotchy mice. Exp. Cell Biol. 45, 1-8. doi: 10.1159/000162853
136. Silvers, W. K. (ed.). (1979). ‘‘X-linked determinants,’’ in The Coat Colour of Mice, Model for Mammalian Gene Action and Interaction, (New York: Springer-Verlag), 159-184.
137. Skjørringe, T., Turner, Z., and Møller, L. B. (2011). Splice site mutations in the ATP7A gene. PLoS One 11:e18599. doi: 10.1371/journal.pone.0018599
138. Southon, A., Burke, R., Norgate, M., Batterham, P., and Camakaris, J. (2004). Copper homoeostasis in Drosophila melanogaster S2 cells. Biochem. J. 383, 303-309. doi: 10.1042/bj20040745
139. Southon, A., Palstra, N., Veldhuis, N., Gaeth, A., Robin, C., Burke, R., et al. (2010). Conservation of copper-transporting P(IB)-type ATPase function. Biometals 23, 681-694. doi: 10.1007/s10534-010-9332-2
140. Steveson, T. C., Ciccotosto, G. D., Ma, X. M., Mueller, G. P., Mains, R. E., and Eipper, B. A. (2003). Menkes protein contributes to the function of peptidylglycine a-amidating monooxygenase. Endocrinology 144, 188-200. doi: 10.1210/en.2002-220716
141. Styrna, J. (1977). Analysis of causes of lethality in mice with Ms (mosaic) gene. Genet. Polon. 18, 61-79.
142. Suzuki, M., and Gitlin, J. D. (1999). Intracellular localization of Menkes and Wilson disease proteins and their intracellular copper transport. Pediatr. Int. 41, 436-442. doi: 10.1046/j.1442-200x.1999.01090.x
143. Suzuki-Kurasaki, M., Okabe, M., and Kurasaki, M. (1997). Copper-metallotionein in the kidney of macular mice: a model for Menkes disease. J. Histochem. Cytochem. 45, 1493-1501. doi: 10.1177/002215549704501106
144. Tanaka, K., Kobayashi, K., Fuita, Y., Fukuhara, C., Onosaka, S., and Min, K. (1990). Effects of chelators on copper therapy of macular mouse, a model animal of Menkes’ kinky disease. Res. Commun. Chem. Phatol. Pharmacol. 69, 217-227.
145. Tang, J., Robertson, S., Lem, K. E., Godwin, S. C., and Kaler, S. G. (2006). Functional copper transport explains neurologic sparing in occipital horn syndrome. Genet. Med. 8,711-718. doi: 10.1097/01.gim.0000245578.94312.1e
146. Telianidis, J., Hung, Y. H., Materia, S., and Fontaine, S. L. (2013). Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front. Aging Neurosci. 5:44. doi: 10.3389/fnagi.2013.00044
147. Tumer, Z. (2013).An overview and update ofATP7A mutations leadingtoMenkes disease and occipital horn syndrome. Hum. Mutat. 34, 417-429. doi: 10.1002/humu.22266
148. Tumer, Z., Birk Møller, L., and Horn, N. (2003). Screening of 383 unrelated patients affected with Menkes disease and finding of 57 gross deletions in ATP7A. Hum. Mutat. 22, 457-464. doi: 10.1002/humu.10287
149. Tumer, Z., Horn, N., Tønnesen, T., Christodoulou, J., Clarke, J. T., and Sarkar, B. (1996). Earlycopper-histidine treatment for Menkes disease. Nat. Genet. 12, 11-13. doi: 10.1038/ng0196-11
150. Tumer, Z., and M0ller, L. B. (2010). Menkes disease. Eur. J. Hum. Genet. 5, 511-518. doi: 10.1038/ejhg.2009.187
151. van den Berghe, P. V., and Klomp, L. W. (2010). Posttranslational regulation of copper transporters. J. Biol. Inorg. Chem. 15, 37-46. doi: 10.1007/s00775-009-0592-7
152. Veronesi, M. C., Kubek, D. J., and Kubek, M. J. (2007). Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat. Epilepsia 48, 2280-2286. doi: 10.1111/j.1528-1167.2007.01218.x
153. Verrotti, A., Cusmai, R., Darra, F., Martelli, P., Accorsi, P., Bergamo, S., et al. (2014). Epilepsy in Menkes disease: an electroclinical long-term study of 28 patients. Epilepsy Res. 108, 1597-1603. doi: 10.1016/j.eplepsyres.2014.08.006
154. Viatte, L., and Vaulont, S. (2009). Hepcidin, the iron watcher. Biochimie 91, 1223-1228. doi: 10.1016/j.biochi.2009.06.012
155. Vulpe, C. D., Kuo, Y. M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., et al. (1999). Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21, 195-199. doi: 10.1038/5979
156. Wenk, G., and Suzuki, K. (1983). Congenital copper deficiency: copper therapy and dopamine-beta-hydroxylase activity in the mottled (brindled) mouse. J. Neurochem. 41, 1648-1652. doi: 10.1111/j.1471-4159.1983.tb00876.x
157. White, S. R., Reese, K., Sato, S., and Kaler, S. G. (1993). Spectrum ofEEG findings in Menkes disease. Electroencephalogr. Clin. Neurophysiol. 87, 57-61. doi: 10.1016/0013-4694(93)90175-u
158. Xu, G. Q., Yamano, T., and Shimada, M. (1994). Copper distribution in fetus and placenta of the macular mutant mouse as a model of Menkes kinky hair disease. Biol.Neonate 66, 302-310.doi: 10.1159/000244121
159. Yamano, T., Shimada, M., Kawasaki, H., Onaga, A., and Nishimura, M. (1987). Clinico-pathological study on macular mutant mouse. Acta Neuropathol. 72, 256-260. doi: 10.1007/bf00691098
160. Yi, L., and Kaler, S. (2014). ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A. Ann. N Y Acad. Sci. 1314, 49-54. doi: 10.1111/nyas.12427
161. Yoshida, K., Furihata, K., Takeda, S., Nakamura, A., Yamamoto, K., Morita, H., et al. (1995). A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9, 267-272. doi: 10.1038/ng0395-267
162. Zaffanello, M., Maffeis, C., Fanos, V., Franchini, M., and Zamboni, G. (2006). Urological complication and copper replacement in childhood Menkes syndrome. Acta Pediatr. 95, 785-790. doi: 10.1111/j.1651-2227.2006.tb02341.x
163. Zelko, I. N., Marian, T. J., and Folz, R. J. (2002). Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2) and EC-SOD (SOD3) gene structures, evolution and expression. Free Radic. Biol. Med. 33, 337-349. doi: 10.1016/s0891-5849(02)00905-x
164. Zheng, W., and Monnot, A. D. (2012). Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol. Ther. 133, 177-188. doi: 10.1016/j.pharmthera.2011.10.006